US 12,473,527 B2
Optimized genetic tool for modifying bacteria
Nicolas Lopes Ferreira, Croisilles (FR); Rèmi Hocq, Paris (FR); and François Wasels, Metz (FR)
Assigned to IFP ENERGIES NOUVELLES, Rueil-Malmaison (FR)
Appl. No. 17/611,962
Filed by IFP ENERGIES NOUVELLES, Rueil-Malmaison (FR)
PCT Filed May 22, 2020, PCT No. PCT/FR2020/050853
§ 371(c)(1), (2) Date Nov. 17, 2021,
PCT Pub. No. WO2020/240122, PCT Pub. Date Dec. 3, 2020.
Claims priority of application No. 1905485 (FR), filed on May 24, 2019.
Prior Publication US 2022/0243170 A1, Aug. 4, 2022
Int. Cl. C12N 1/20 (2006.01); C12N 9/22 (2006.01); C12N 15/10 (2006.01); C12N 15/11 (2006.01); C12N 15/113 (2010.01); C12N 15/74 (2006.01); C12N 15/90 (2006.01); C12R 1/145 (2006.01)
CPC C12N 1/205 (2021.05) [C12N 9/22 (2013.01); C12N 15/102 (2013.01); C12N 15/111 (2013.01); C12N 15/113 (2013.01); C12N 15/74 (2013.01); C12N 15/902 (2013.01); C12N 2310/20 (2017.05); C12R 2001/145 (2021.05)] 3 Claims
OG exemplary drawing
 
1. A bacterium C. beijerinckii deposited under deposit number LMG P-31277 with BCCM-LMG or a genetically modified version thereof, wherein said genetically modified version is sensitive to an amphenicol and lacks pNF2.